lysine has been researched along with Atheroma in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (66.67) | 24.3611 |
2020's | 3 (33.33) | 2.80 |
Authors | Studies |
---|---|
Battle, S; Cameron, SJ; Crabb, JW; DiDonato, JA; Fu, X; Gogonea, V; Graham, LM; Hazen, SL; Huang, Y; Wang, Z; Willard, B | 1 |
Li, P; Wang, J; Xu, X; Zhang, B; Zhang, J | 1 |
Ai, D; Cao, Y; Cheng, T; Du, J; Jiang, H; Liu, M; Liu, T; Lv, H; Lv, X; Tian, Y; Wang, B; Xiang, S; Yan, M; Zhang, H; Zhang, X; Zhou, F; Zhu, Y | 1 |
Aikawa, H; Eto, A; Hanada, H; Hiraoka, F; Iko, M; Inoue, R; Kazekawa, K; Kiyomi, F; Mitsutake, T; Nagai, R; Nii, K; Sakamoto, K; Sakata, N; Shirakawa, JI; Tsutsumi, M | 1 |
Bao, Z; Dai, Z; Jing, L; Li, L; Shao, C; Sun, Z; Wang, Z; Xu, S; Yan, J; Ye, F; Zhu, J | 1 |
Barbé, F; Benabdelhak, I; Bermúdez-López, M; Betriu, À; Colàs-Campàs, L; Farràs, C; Fernández, E; Hernández, C; Hernández, M; Jové, M; Kerkeni, M; Lecube, A; Manuel Valdivielso, J; Martínez-Alonso, M; Miquel, E; Ortega, M; Pamplona, R; Polanco, D; Portero-Otin, M; Purroy, F; Rius, F; Sánchez, E; Sánchez-de-la-Torre, M; Simó, R; Suárez, G; Torres, G; Yeramian, A | 1 |
Culmes, M; Eckstein, HH; Gebhard, H; Greißel, A; Napieralski, R; Pelisek, J; Schmitt, M; Wagner, E; Zernecke, A; Zimmermann, A | 1 |
Ikeda, T; Ito, N; Kurita, H; Maruyama, K; Shimada, A; Shiokawa, Y; Utagawa, A | 1 |
Furfaro, AL; Monacelli, F; Odetti, P; Pronzato, MA; Puzzo, A; Sanguineti, R; Storace, D; Traverso, N | 1 |
9 other study(ies) available for lysine and Atheroma
Article | Year |
---|---|
The pattern of apolipoprotein A-I lysine carbamylation reflects its lipidation state and the chemical environment within human atherosclerotic aorta.
Topics: Aorta; Apolipoprotein A-I; Atherosclerosis; Humans; Isocyanates; Lipoproteins, HDL; Lysine; Plaque, Atherosclerotic; Protein Carbamylation; Proteomics; Urea | 2022 |
MicroRNA-200a Inhibits Inflammation and Atherosclerotic Lesion Formation by Disrupting EZH2-Mediated Methylation of STAT3.
Topics: Animals; Apoptosis; Atherosclerosis; Cells, Cultured; Disease Models, Animal; Enhancer of Zeste Homolog 2 Protein; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Lipoproteins, LDL; Lysine; Male; Methylation; Mice, Knockout, ApoE; MicroRNAs; Phosphorylation; Plaque, Atherosclerotic; Signal Transduction; STAT3 Transcription Factor | 2020 |
Macrophage K63-Linked Ubiquitination of YAP Promotes Its Nuclear Localization and Exacerbates Atherosclerosis.
Topics: Adaptor Proteins, Signal Transducing; Animals; Atherosclerosis; Cell Cycle Proteins; Cell Line; Cell Movement; Cell Nucleus; Chemokines; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Lysine; Macrophages; Male; Mice, Inbred C57BL; Models, Biological; Monocytes; Plaque, Atherosclerotic; Protein Binding; Protein Stability; Protein Transport; TNF Receptor-Associated Factor 6; Transcription Factors; Ubiquitination; Up-Regulation; YAP-Signaling Proteins | 2020 |
N
Topics: Aged; Aged, 80 and over; Biomarkers; Carotid Arteries; Carotid Stenosis; Chi-Square Distribution; Chromatography, Liquid; Diffusion Magnetic Resonance Imaging; Embolic Protection Devices; Endovascular Procedures; Enzyme-Linked Immunosorbent Assay; Female; Humans; Linear Models; Lysine; Magnetic Resonance Angiography; Male; Molecular Imaging; Multivariate Analysis; Peroxidase; Plaque, Atherosclerotic; Predictive Value of Tests; Registries; Risk Assessment; Risk Factors; Stents; Tandem Mass Spectrometry; Treatment Outcome | 2017 |
CML/CD36 accelerates atherosclerotic progression via inhibiting foam cell migration.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; CD36 Antigens; Cell Migration Inhibition; Cell Movement; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Disease Progression; Foam Cells; Glycation End Products, Advanced; Lysine; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Plaque, Atherosclerotic; RAW 264.7 Cells | 2018 |
Skin Autofluorescence Measurement in Subclinical Atheromatous Disease: Results from the ILERVAS Project.
Topics: Arginine; Case-Control Studies; Cross-Sectional Studies; Female; Fluorescence; Follow-Up Studies; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Optical Imaging; Plaque, Atherosclerotic; Prognosis; Prospective Studies; ROC Curve; Skin | 2019 |
Alternation of histone and DNA methylation in human atherosclerotic carotid plaques.
Topics: Aged; Blood Cells; Carotid Arteries; Carotid Artery Diseases; Disease Progression; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA-Binding Proteins; Enzyme Induction; Female; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Humans; Inflammation; Leukocytes; Long Interspersed Nucleotide Elements; Lysine; Macrophages; Male; Methylation; Middle Aged; Mixed Function Oxygenases; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neoplasm Proteins; Plaque, Atherosclerotic; Protein Processing, Post-Translational; Proto-Oncogene Proteins; Real-Time Polymerase Chain Reaction | 2015 |
High serum pentosidine in branch atheromatous disease among small vessels occlusion.
Topics: Aged; Aged, 80 and over; Arginine; Brain Ischemia; Diffusion Magnetic Resonance Imaging; Disease Progression; Female; Humans; Lysine; Male; Middle Aged; Plaque, Atherosclerotic; Prognosis; Risk Factors; Sensitivity and Specificity | 2019 |
Metalloproteinases and advanced glycation end products: coupled navigation in atherosclerotic plaque pathophysiology?
Topics: Aged; Arginine; Atherosclerosis; Biomarkers; Carotid Artery, Internal; Carotid Stenosis; Diabetic Angiopathies; Extracellular Matrix; Gene Expression Regulation; Glycation End Products, Advanced; Humans; Inflammation Mediators; Interleukin-1alpha; Italy; Lysine; Matrix Metalloproteinase 2; Metalloproteases; Plaque, Atherosclerotic; Risk Factors; Severity of Illness Index; Tissue Inhibitor of Metalloproteinase-3 | 2012 |